Cargando…
Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer
MicroRNA-137 (miR-137) functions as a tumor suppressor and is silenced by aberrant promoter methylation. Previous studies have demonstrated that miR-137 is downregulated in lung cancer. The purpose of the present study was to investigate miR-137 promoter methylation and to assess its prognostic valu...
Autores principales: | Min, Lingfeng, Wang, Fang, Hu, Suwei, Chen, Yong, Yang, Junjun, Liang, Sudong, Xu, Xingxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934732/ https://www.ncbi.nlm.nih.gov/pubmed/29740491 http://dx.doi.org/10.3892/ol.2018.8273 |
Ejemplares similares
-
miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer
por: Luo, Yutu, et al.
Publicado: (2022) -
Downregulation of Six MicroRNAs Is Associated with Advanced Stage, Lymph Node Metastasis and Poor Prognosis in Small Cell Carcinoma of the Cervix
por: Huang, Long, et al.
Publicado: (2012) -
Identification of Neck Lymph Node Metastasis-Specific microRNA—Implication for Use in Monitoring or Prediction of Neck Lymph Node Metastasis
por: Higashi, Yutaro, et al.
Publicado: (2023) -
Menopausal status and the risk of lung cancer in women: A PRISMA-compliant meta-analysis
por: Min, Lingfeng, et al.
Publicado: (2017) -
Identification of candidate genes or microRNAs associated with the lymph node metastasis of SCLC
por: Wang, Zhonghao, et al.
Publicado: (2018)